- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
18
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
18 companies
OS Therapies
Market Cap: US$46.3m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.58
7D
-2.5%
1Y
n/a
ARS Pharmaceuticals
Market Cap: US$1.8b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$17.56
7D
3.6%
1Y
54.9%
Corcept Therapeutics
Market Cap: US$7.7b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$71.41
7D
4.8%
1Y
114.2%
Eton Pharmaceuticals
Market Cap: US$389.9m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$14.43
7D
-8.7%
1Y
301.9%
TuHURA Biosciences
Market Cap: US$108.5m
A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
HURA
US$2.30
7D
-7.3%
1Y
n/a
NRx Pharmaceuticals
Market Cap: US$55.5m
A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.
NRXP
US$3.11
7D
-8.0%
1Y
24.4%
BioRestorative Therapies
Market Cap: US$12.0m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.54
7D
-10.5%
1Y
-12.0%
Liquidia
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$14.51
7D
13.5%
1Y
13.1%
Krystal Biotech
Market Cap: US$4.3b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$147.73
7D
3.1%
1Y
-29.2%
TriSalus Life Sciences
Market Cap: US$188.4m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.
TLSI
US$4.74
7D
-8.3%
1Y
-12.3%
Protalix BioTherapeutics
Market Cap: US$113.0m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.38
7D
-6.8%
1Y
17.9%
Journey Medical
Market Cap: US$172.6m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.98
7D
0.9%
1Y
18.1%
Clene
Market Cap: US$33.5m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$3.70
7D
-2.6%
1Y
-24.5%
Harrow
Market Cap: US$1.3b
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$34.37
7D
10.8%
1Y
38.5%
ALT5 Sigma
Market Cap: US$121.5m
Provides blockchain-powered technologies worldwide.
ALTS
US$7.17
7D
-0.3%
1Y
217.3%
Aprea Therapeutics
Market Cap: US$9.4m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.63
7D
-9.4%
1Y
-59.1%
Niagen Bioscience
Market Cap: US$888.8m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$11.08
7D
-7.4%
1Y
260.9%
Bruker
Market Cap: US$6.5b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$41.96
7D
-0.9%
1Y
-36.7%